Business Context and Reporting Period
Company: The Scotts Miracle-Gro Company (SMG)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended September 30, 2025
Business Overview: SMG is the leading marketer of branded consumer lawn and garden products in North America. Operations are divided into three segments: U.S. Consumer (lawn and garden products), Hawthorne (indoor and hydroponic gardening), and Other (primarily Canada). The company holds an exclusive marketing agreement for Monsanto's Roundup brand in the U.S.
Key Financial Metrics (Fiscal 2025)
| Metric | Fiscal 2025 | Fiscal 2024 | Fiscal 2023 |
|---|---|---|---|
| Net Sales | $3,413.1 million | $3,552.7 million | $3,551.3 million |
| Gross Margin | $1,044.2 million (30.6%) | $850.5 million (23.9%) | $657.3 million (18.5%) |
| Operating Income | $358.6 million | $208.8 million | $(174.4) million |
| Net Income | $145.2 million | $(34.9) million | $(380.1) million |
| Diluted EPS | $2.47 | $(0.61) | $(6.79) |
| Operating Cash Flow | $371.3 million | $667.5 million | $531.0 million |
| Total Debt | $2,119.7 million | $2,242.8 million | N/A |
| Cash & Equivalents | $36.6 million | $71.6 million | $31.9 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.9% to $3,413.1 million, driven by a 43.7% drop in Hawthorne segment sales (due to cannabis market oversupply and discontinuation of third-party product distribution) and lower pricing in the U.S. Consumer segment.
- Margin Expansion: Gross margin rate improved significantly to 30.6% from 23.9% in 2024. This was driven by lower material costs, favorable product mix, reduced warehousing/transportation costs, and a decrease in impairment charges.
- Profitability Turnaround: The company returned to profitability with $145.2 million in net income, reversing a $34.9 million loss in 2024. This was aided by a reduction in impairment, restructuring, and other charges from $146.3 million in 2024 to $83.8 million in 2025.
- Debt Reduction: Total debt decreased by approximately $123 million as the company utilized cash flow to repay term loans.
Guidance, Outlook, and Risks
- Capital Allocation: Fiscal 2026 capital expenditures are expected to be approximately $100.0 million, allocated toward maintenance (46%), cost savings (28%), and innovation/expansion (26%).
- Debt Covenants: On November 21, 2025, the company entered a new credit agreement (Seventh A&R) with a maximum permitted leverage ratio of 5.00 and minimum interest coverage ratios ranging from 3.00 to 3.50 depending on the fiscal quarter.
- Key Risks:
- Customer Concentration: The Home Depot and Lowe's accounted for 52% of fiscal 2025 net sales.
- Hawthorne Segment: Continued adverse impact from cannabis market oversupply and regulatory uncertainty.
- Roundup Agreement: Termination of the exclusive marketing agreement with Monsanto could result in the loss of a substantial earnings source.
- Regulatory: Increasing scrutiny on PFAS chemicals, packaging regulations, and pesticide use.
- Legal Proceedings: The company is defending against consolidated securities litigation alleging misstatements regarding inventories and sales, as well as asbestos-related claims, though no accruals have been recorded for the latter.
Investor Verification Checklist
- Customer Concentration: Verify the stability of relationships with The Home Depot and Lowe's, which represent over half of total revenue.
- Hawthorne Segment Viability: Assess the long-term outlook for the hydroponic segment given the persistent oversupply in the cannabis market.
- Roundup Agreement Terms: Review the specific termination triggers and financial implications of the Monsanto marketing agreement.
- Debt Service Capacity: Monitor the company's ability to maintain the new leverage and interest coverage ratios under the Seventh A&R Credit Agreement.
- Regulatory Exposure: Evaluate potential costs associated with evolving PFAS regulations and extended producer responsibility laws for packaging.